Professor Lucille Blumberg is a deputy director at the National Institute for Communicable Diseases, a branch of the National Health Laboratory Service, and is based in Johannesburg, South Africa. She heads the Epidemiology Division, which includes the units for Outbreak Response, Travel and International Health, Epidemiology and Surveillance, as well as the Field Epidemiology and Laboratory Training programme. She is the medical consultant to the Special Pathogens Unit on rabies and Viral Haemorrhagic fevers.

William Brieger is Professor in the Health Systems Program of the Department of International Health at The Johns Hopkins Bloomberg School of Public Health and also serves as JHPIEGO’s Senior Malaria Specialist. William is a Certified Health Education Specialist and has a Doctorate in Public Health (DrPH) in international health from the Johns Hopkins University (JHU) and a Masters in Public Health (MPH) from the University of North Carolina, Chapel Hill. Bill taught at the African Regional Health Education Center at the University of Ibadan, Nigeria, from 1976 to 2002. He is internationally renowned for his expertise in the social and behavioral aspects of tropical disease control and prevention, with special emphasis on malaria, onchocerciasis and guineaworm.

Dr Muhwa Chakaya is Chief Research Officer and Consultant Chest Physician at Kenya Medical Research Institute.

Moupali Das is Assistant Clinical Professor the University of California, San Francisco.

Steven G. Deeks, MD, is a Professor of Medicine in Residence at the University of California, San Francisco (UCSF) and a faculty member in the Positive Health Program (AIDS Program) at San Francisco General Hospital. Dr. Deeks has been engaged in HIV research and clinical care since 1993. He is an expert on the role of chronic inflammation in untreated and treated HIV disease. His research has several linked objectives, including: (1) to determine the mechanisms which contribute to this persistent inflammation during therapy, (2) to characterize the impact of persistent inflammation during antiretroviral therapy on end-organ disease and function, (3) to determine the impact of inflammation and immune dysfunction on HIV persistence during effective therapy and (4) to develop novel therapeutic interventions which reduce chronic inflammation and/or the size of the latent reservoir.

Thom Eisele is an Associate Professor at the Tulane School of Public Health and Tropical Medicine and the Director of the Center for Applied Malaria Research and Evaluation. His research focuses on malaria epidemiology and evaluating malaria control and elimination strategies. Areas of expertise include malaria epidemiology, evaluating the impact of malaria control/elimination strategies, and measurement of malaria intervention coverage and malaria health outcomes. His current research focuses on measuring the impact of focal mass drug administration aimed at eliminating malaria in Southern Province Zambia through a collaborates with the Malaria Control and Evaluation Partnership in Africa (MACEPA) with funding from Bill and Melinda Gates Foundation. Dr. Eisele is a member of the Roll Back Malaria Monitoring and Evaluation Reference Group, the Technical Expert Group on Surveillance, Monitoring and Evaluation for the WHO Global Malaria Program, and was previously a Malaria Expert Group member of the WHO Child Health Epidemiology Reference Group.

Jerrold J. Ellner, MD, has been appointed chief of the section of infectious diseases at Boston Medical Center and professor of medicine in the department of medicine at Boston University School of Medicine. Ellner previously had served as chair of the department of medicine at the New Jersey Medical School of the University of Medicine and Dentistry of New Jersey from 2002 to 2006, and was most recently professor of medicine and scientific director of the Center for Emerging Pathogens at UMDNJ. Ellner joined the faculty at Case Western Reserve University as an assistant professor in 1976 and was promoted to professor of medicine and pathology in 1983. He served as chief of the division of infectious diseases at Case Western Reserve University and University Hospitals of Cleveland from 1979 through 1996. Ellner also served as vice-chair, executive vice chair and interim chair of the department of medicine at Case Western Reserve University. He was director of the Tuberculosis Research Unit at Case Western Reserve University from 1994 through 1999.

Dr Christopher Gilpin is Scientist in the TB Diagnostics and Laboratory Strengthening Unit (TBL) of the Global TB Programme. He has over twenty years experience as a Microbiology Laboratory Scientist managing diagnostic laboratories in Australia and the Middle-East.

Dr Philippe Glaziou is Senior Epidemiologist at the World Health Organization. He leads the epidemiology sub-team of the Global TB Programme at WHO Headquarters in Geneva since 2008. Prior to joining the WHO in 2004 at the Regional Office for the Western Pacific (Manila, Philippines), he has worked with Institute Pasteur (Paris, France) in the capacity of clinical research laboratory head and has been posted in different countries including Cambodia, Central African Republic and French Polynesia.

Dr. Malgorzata Grzemska works in the WHO’s Global TB Programme in Geneva. She is responsible for coordinating technical assistance to regions and countries in implementing Stop TB Strategy, development of treatment policies on TB and Childhood TB. Dr Grzemska started her international career in 1994 when she joined WHO. She specialized in Pediatrics and obtained a PhD in 1989 and a public health specialty in 2004. Dr Grzemska is an author and co-author of several publications.

Davidson Hamer, MD, FACP, FIDSA, is a Professor of International Health and Medicine at the Boston University School of Public Health and School of Medicine, and Adjunct Professor of Nutrition at the Tufts University Friedman School of Nutrition Science and Policy. Dr. Hamer is a board-certified specialist in infectious diseases, with a particular interest in tropical infectious diseases, and has twenty years of field experience in neonatal and child survival research including studies of micronutrient interventions, maternal and neonatal health, malaria, pneumonia, and diarrheal diseases. During the last 15+ years, he has supervised and provided technical support to more than 50 studies in developing countries that evaluated interventions for improving neonatal survival, treatment and prevention of malaria, HIV/AIDS, micronutrient deficiencies, diarrheal disease, and pneumonia. He currently has active projects in Zambia, Tanzania, and Ecuador.

Bradley Hare, MD is Associate Professor of Clinical Medicine and Medical Director, UCSF HIV/AIDS Division at San Francisco General Hospital. He conducts patient-based research on a variety of topics important to HIV clinical management, the inspiration for which comes directly from observations in the clinic. Current areas of focus include HIV and Hepatitis C Virus (HCV) co-infection, where he studies the epidemiology, natural history and treatment of acute hepatitis C infection, the use of novel agents in the treatment of HIV-HCV co-infection, and models of HCV treatment in primary care settings. He also conducts research on HIV testing in medical settings such as the Emergency Department, linkage to care after HIV testing, and implementation of a patient-centered medical home for people aging with HIV infection.

Dr Ajay Kumar currently works as the Deputy Director (Center for Operational Research) of the International Union Against Tuberculosis and Lung Disease and also leads the operational research initiatives of the South-East Asia Regional office. He is actively involved in conducting and publishing operational research in TB, HIV and Diabetes Mellitus. He organizes and facilitates many international and national courses on operational research and mentors young researchers across the globe (India, Asia, Africa, Europe and South Pacific).

Dr Luetkemeyer is an assistant professor of medicine at University of California San Francisco (UCSF) and an attending physician at San Francisco General Hospital (SFGH) where she specializes in HIV/AIDS. Her clinical responsibilities include outpatient services at the San Francisco General Hospital HIV clinic as well as inpatient services on the HIV/AIDS, general medicine, and infectious diseases consult services. Dr Luetkemeyer directs the HIV Clinical Trials Group at SFGH, which conducts investigator-initiated and industry HIV trials. She is a site investigator for the Adult AIDS Clinical Trials Group (ACTG). Her research interests include HIV and tuberculosis coinfection, development of novel tuberculosis diagnostics, and HIV and viral hepatitis coinfection.

Dr. Alan Magill oversees the development and implementation of strategies for the Gates foundation’s ultimate goal of the eradication of malaria using current tools and strategies as well as developing new generations of vaccines, diagnostics, and anti-malarial therapies to be used in novel and innovative ways.

Before joining the Global Health Program in 2012, Dr. Magill worked at the Defense Advanced Research Program Agency (DARPA), and was responsible for accelerating program development for their pandemic influenza initiative. Dr. Magill has also served as Head of Parasitology at the US Navy’s Medical Research Center in Peru and has lived in Germany, where he was a clinician.

Dr. Magill is board-certified in internal medicine with a subspecialization in infectious disease. He graduated with a Bachelor’s degree from Lamar University, has a Master of Science from the University of Rhode Island and an MD from Baylor University. He completed his residency at the Tripler Army Medical Center in Hawaii, the headquarters of the Pacific Regional Medical Command.

Kevin Marsh is Professor of Tropical Medicine at Oxford University, Nuffield Department of Medicine. He is also the Director of the KEMRI Wellcome Trust Research Programme, chair of the Oxford Tropical Network and chair of the WHO Malaria Policy Advisory Committee recently established to advise the Director general of the WHO on malaria.

Giovanni B Migliori is Director of the WHO Collaboration Centre for Lung Diseases.

Dr Elena Stylianou is a post-doctoral research scientist at the Jenner Institute, University of Oxford UK. She works in the group of Prof. Helen McShane, developing novel vaccines against TB. She has been working in the field of TB vaccines for the past 8 years.

Steve Taylor is an infectious diseases clinician and is transitioning to independence as a laboratory-based investigator in translational studies of falciparum malaria in children and pregnant women. He contributes to DGHI’s educational mission by delivering seminars, contributing to courses, and mentoring MScGH students interested in clinical or laboratory studies of malaria. From a research perspective, he anticipates designing projects with DGHI field partners in Eldoret, Kenya and enhancing nascent research efforts in Kigali, Rwanda. Finally, he maintains active collaborations with investigators working in more than a dozen African countries and hope to enhance their connections with Duke. He hopes to use malaria research as a tool to enhance educational and research products of Duke and investigators in malaria-endemic areas.

Professor Nicholas White is Professor of Tropical Medicine at the Faculty of Tropical Medicine, Mahidol University and Oxford University, and is also a Consultant Physician at the John Radcliffe Hospital, Oxford, UK. He chairs the Wellcome Trust Tropical Medicine Research Programme in South-East Asia, and the Oxford Tropical Medicine Network (encompassing research groups in Thailand, Vietnam, Laos, Kenya and The Gambia). He also currently co-chairs the World Health Organisation antimalarial treatment guidelines committee and the WHO Global Malaria Programme case management cluster.

He is currently on the Editorial or Advisory Boards of 13 scientific journals including The Lancet, PLOS Medicine, the European Journal of Clinical Pharmacology and Antimicrobial Agents and Chemotherapy. He has published over 880 scientific papers and over 40 book chapters.